Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

6 Stocks To Watch: ABBV, FSLY, GDOT, PTGX, SIEN, UNFI

Published 05/12/2020, 11:44 PM
Updated 07/09/2023, 06:31 AM

1. AbbVie (NYSE:ABBV), a biopharma research company, had a nice pop on Tuesday after reaching a session high of 92.23, and gaining 2.56, or 2.9%, to 90.46, on 22 million shares traded. That is the biggest volume in quite a while. There is a short-term peak at resistance. It is either going to pull back or blow through it to the 96-98 zone.

2. Fastly (NYSE:FSLY), a provider of edge cloud platform, formed a V-bottom mid-March, then a right-hand extension, broke out with a breakaway gap, and on Tuesday, it advanced to the highs, jumping 2.78, or 8%, to 37.10, with a multi-week and session high of 38.98, on 6.7 million shares traded. I don’t know if it’s ready to pull back, but you may see low to mid 40’s before it is.

3. Green Dot (NYSE:GDOT) financial technology popped, ran, and settled on an increase of 4.14, or 13 1/2%, to 34.84, with a session high of 36.52, on a solid 1.7 million shares traded. Watch the spike high at 39 3/4, which is my next target.

4. Protagonist Therapeutics (NASDAQ:PTGX) popped out of a one-day pullback on Tuesday, adding another 1.37, or 9.36%, to 16.00, with a multi-week and session high of 17.33, on 3.6 million shares traded and an additional 30 cents in after-hours. It is not as steady, and it’s at resistance. If it gets through here, the next target is 23 1/2.

5. Sientra (NASDAQ:SIEN), a medical aesthetics, company, popped out a base on Tuesday. It didn’t finish great, but it still gained 32.5 cents, or 15.5%, to 2.74, with a high of 3.31, on 8.4 million shares traded. The next target is 4.40.

6. United Natural Foods (NYSE:UNFI) broke out of a wedge on Tuesday, and moved up 2.83, or 22%, to 15.51, after reaching a multi-week and session high of 16.70, on 4.6 million shares traded, and another 96 cents in after-hours. UNFI might extend. If it does, my target is 19 3/4.

Stocks on the long side

AbbVie Inc. (ABBV), Altimmune, Inc. (NASDAQ:ALT), Alpha Pro Tech, Ltd. (APT), Atomera Incorporated (ATOM), B&G Foods, Inc. (NYSE:BGS), BioSig Technologies, Inc. (NASDAQ:BSGM), Collegium Pharmaceutical, Inc. (NASDAQ:COLL), ddog, Eldorado Resorts, Inc. (NASDAQ:ERI), Fastly, Inc. (FSLY), Green Dot Corporation (GDOT), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Livongo Health, Inc. (NASDAQ:LVGO), MacroGenics, Inc. (NASDAQ:MGNX), MyoKardia, Inc. (NASDAQ:MYOK), NanoViricides, Inc. (NNVC), Novavax, Inc. (NASDAQ:NVAX), Overstock.com, Inc. (NASDAQ:OSTK), Protagonist Therapeutics, Inc. (PTGX), Peloton Interactive, Inc. (NASDAQ:PTON), Schrodinger, Inc. (NASDAQ:SDGR), Sientra, Inc. (SIEN), United Natural Foods, Inc. (UNFI), Veritone, Inc. (NASDAQ:VERI), and VectoIQ Acquisition Corp. (VTIQ).

Watch video here...

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Fastly passed what it did in the summer.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.